AFYA

Afya Limited

• Simply Wall St·2d ago

  Afya (NasdaqGS:AFYA) Valuation Check After Mixed Short Term And Three Year Shareholder Returns

• NASDAQ·4d ago

  Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know

• Simply Wall St·05/10 02:35

  Afya’s Solid Earnings Meet Valuation Discount And AI Headwinds

• Benzinga·05/08 13:59

  Reported earlier, Afya Affirms FY2026 Sales Guidance of $731.710M-$759.496M vs $760.310M Est

• Benzinga·05/08 09:37

  Reported Earlier, Afya Q1 EPS $0.55 Beats $0.54 Estimate, Sales $192.330M Beat $191.870M Estimate

• Seeking Alpha·05/08 05:52

  Afya GAAP EPS of R$2.85, revenue of R$1.01B; reaffirms FY26 outlook

• Seeking Alpha·05/07 22:44

  70 May Graham Value All-Stars ('GVAS'): 13 To Buy

• PUBT·05/07 22:24

  Afya publishes 1Q26 financial results presentation

• PUBT·05/07 20:45

  Afya 1Q26 net income rises 1.8% to R$ 261.8 million; revenue increases 8.2% to R$ 1.01 billion

• TipRanks·05/07 20:38

  Afya Posts Solid Q1 2026 Results, Expands Medical Seats and Keeps AAA.br Rating

• TipRanks·05/07 20:37

  Afya Posts Higher First-Quarter 2026 Revenue and Earnings in Unaudited Results

• PUBT·05/06 11:51

  Moody's reaffirms Afya at AAA.br rating, outlook stable

• PUBT·05/06 00:59

  Moody's reaffirms Afya AAA.br rating, outlook stable

• Dow Jones·04/30 21:25

  Afya Is Maintained at Neutral by JP Morgan

• Dow Jones·04/30 21:25

  Afya Price Target Cut to $21.50/Share From $22.00 by JP Morgan